Status:
COMPLETED
Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Erectile Dysfunction
Sigmoid Colon Cancer
Eligibility:
MALE
19-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy of Udenafil (Zydena®, Dong-A Pharmaceutical co., Ltd, Seoul, Korea) in treatment of erectile dysfunction after radical resection for sigmoid colon...
Detailed Description
Post-pelvic surgery erectile dysfunction is of much interest to those performing sigmoid colon and rectal cancer surgery and their patients. Erectile dysfunction has been recognized to develop from da...
Eligibility Criteria
Inclusion
- • Male patients between 19-70 years old in good general health
- Patient willing to treat postoperative erectile dysfunction and participate in the study
- Patient who understands and accepts to sign the informed consent form
- Patient who received radical resection for sigmoid colon and rectal cancer. : erectile dysfunction was developed following operation, not preoperatively
- Scores of IIEF-5 measured at 12 months after surgery is 16 or less
Exclusion
- • Documented problem of preoperative erectile dysfunction
- Past history of myocardial infarction, cerebrovascular disease
- Under administration of nitrate
- Liver dysfunction (SGOT or SGPT 100 IU/L or more)
- Kidney dysfunction (serum Creatinine 3mg/dl or more)
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00607282
Start Date
March 1 2009
End Date
January 1 2012
Last Update
September 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Seoul National University Bundang Hospital
Seongnam, South Korea, 463-707